These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 6111009)

  • 1. Effect of melanostatin and thyroliberin on the biosynthesis and release of dopamine by rat brain striatal P2 fractions.
    Shapiro LM; Bowes GM; Vaughan PF
    Life Sci; 1980 Dec; 27(22):2099-108. PubMed ID: 6111009
    [No Abstract]   [Full Text] [Related]  

  • 2. [Regulation of the adenohypophysis by hypothalamic hormones. Biochemistry and physiology of releasing hormones. III. Corticotropin releasing hormone, prolactin releasing hormone, prolactostatin, melanotropin releasing hormone, melanostatin].
    Blech W
    Endokrinologie; 1978 Mar; 71(3):325-36. PubMed ID: 28942
    [No Abstract]   [Full Text] [Related]  

  • 3. Thyrotropin-releasing hormone (TRH) content of rat striatum: modification by drugs and lesions.
    Spindel ER; Pettibone DJ; Wurtman RJ
    Brain Res; 1981 Jul; 216(2):323-31. PubMed ID: 6265032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylphenidate-like stimulants in vitro release [3H]tyramines but not [14C]dopamine.
    Dyck LE
    Eur J Pharmacol; 1981 Jan; 69(3):371-4. PubMed ID: 6111462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of 1-methyl-4-phenylpyridinium ion and tyramine with a site putatively involved in the striatal vesicular release of dopamine.
    Vaccari A; Del Zompo M; Melis F; Gessa GL; Rossetti ZL
    Br J Pharmacol; 1991 Nov; 104(3):573-4. PubMed ID: 1797320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the nature of the releasable pool of dopamine in synaptosomes from rat corpus striatum: depolarization-induced release of 3H-dopamine from superfused synaptosomes labelled under various conditions.
    de Langen CD; Stoof JC; Mulder AH
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Jul; 308(1):41-9. PubMed ID: 492352
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of catecholamine releasing agents on synaptosomal dopamine biosynthesis: multiple pools of dopamine or multiple forms of tyrosine hydroxylase.
    Kuczenski R
    Neuropharmacology; 1975 Jan; 14(1):1-10. PubMed ID: 239360
    [No Abstract]   [Full Text] [Related]  

  • 8. Modification of in vitro neurotransmitter release from rat brain slices by hypophyseotropic factors.
    Mulder AH; Smelik PG
    Prog Brain Res; 1975; 42():67-8. PubMed ID: 736
    [No Abstract]   [Full Text] [Related]  

  • 9. Lack of effect of gamma-butyrolactone on amphetamine-induced decrease in striatal synaptosomal dopamine synthesis.
    Kuczenski R
    J Neurochem; 1978 Jul; 31(1):347-9. PubMed ID: 671029
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential effects of D- and L-amphetamine and methylphenidate on rat striatal dopamine biosynthesis.
    Kuczenski R; Segal DS
    Eur J Pharmacol; 1975 Feb; 30(2):244-51. PubMed ID: 1126362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of 5-hydroxytryptophan and 5-hydroxytryptamine on dopamine synthesis and release in rat brain striatal synaptosomes.
    Andrews DW; Patrick RL; Barchas JD
    J Neurochem; 1978 Feb; 30(2):465-70. PubMed ID: 24089
    [No Abstract]   [Full Text] [Related]  

  • 12. Release of endogenous dopamine and cholecystokinin from rat striatal slices: effects of amphetamine and dopamine antagonists.
    Hutchison JB; Strupish J; Nahorski SR
    Brain Res; 1986 Apr; 370(2):310-4. PubMed ID: 3708329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of rapid superfusion to differentiate the release of dopamine from striatal tissue induced by sympathomimetic amines from release induced by potassium.
    Caviness JN; Wightman RM
    J Pharmacol Exp Ther; 1982 Oct; 223(1):90-6. PubMed ID: 7120132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uptake and release of manganese by rat striatal slices.
    Daniels AJ; Gysling K; Abarca J
    Biochem Pharmacol; 1981 Jul; 30(13):1833-7. PubMed ID: 7271871
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacoethological analysis of the effects of thyroliberin and melanostatin in a model of anxious-defensive behavior in mice].
    Poshivalov VP; Iurkevich AV; Tsakhaev GA
    Biull Eksp Biol Med; 1987 Jun; 103(6):681-3. PubMed ID: 2885047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental studies on the development of sex differences in the release of dopamine from striatal tissue fragments in vitro.
    Becker JB; Ramirez VD
    Neuroendocrinology; 1981 Mar; 32(3):168-73. PubMed ID: 7219671
    [No Abstract]   [Full Text] [Related]  

  • 17. Striatal dopamine release stimulated by amphetamine or potassium: influence of ovarian hormones and the light-dark cycle.
    Becker JB; Beer ME; Robinson TE
    Brain Res; 1984 Oct; 311(1):157-60. PubMed ID: 6488037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphetamine- and phenylethylamine-induced alterations in dopamine synthesis regulation in rat brain striatal synaptosomes.
    Roberts MM; Patrick RL
    J Pharmacol Exp Ther; 1979 Apr; 209(1):104-10. PubMed ID: 430370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic administration of thyrotropin-releasing hormone enhances striatal dopamine release in vivo.
    Kreutz MR; Acworth IN; Lehnert H; Wurtman RJ
    Brain Res; 1990 Dec; 536(1-2):347-52. PubMed ID: 1707722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine-induced release of catecholamines from rat hippocampus and striatum.
    Arqueros L; Naquira D; Zunino E
    Biochem Pharmacol; 1978; 27(23):2667-74. PubMed ID: 728222
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.